An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19

Clin Drug Investig. 2021 Mar;41(3):287-289. doi: 10.1007/s40261-021-01007-8. Epub 2021 Feb 19.

Authors

Jan Homolak¹, Ivan Kodvanj², Vladimir Trkulja²

Affiliations

¹ Department of Pharmacology, University of Zagreb School of Medicine, 10 000, Zagreb, Croatia. homolakjan@gmail.com.
² Department of Pharmacology, University of Zagreb School of Medicine, 10 000, Zagreb, Croatia.

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19*
Humans
Proton Pump Inhibitors / adverse effects
Risk Factors
SARS-CoV-2
Virus Diseases*

Substances

Proton Pump Inhibitors